Carl Zeiss Meditec logo

Carl Zeiss Meditec

Stock
Stock
ISIN: DE0005313704
Ticker: AFX
DE0005313704
AFX

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Carl Zeiss Meditec has so far distributed $0.636 in 2026. The next dividend will be paid on 31.03.2027


$0.572

CHART BY

Frequently asked questions

The market capitalization of Carl Zeiss Meditec is $3.12B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Carl Zeiss Meditec is 28.37. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Carl Zeiss Meditec's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.258. EPS indicates the company's profitability on a per-share basis.
Currently, 17 analysts cover Carl Zeiss Meditec's stock, with a consensus target price of $32.25. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Carl Zeiss Meditec reported a revenue of $2.52B.
Carl Zeiss Meditec's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $376.86M. EBITDA measures the company's overall financial performance.
Carl Zeiss Meditec has a free cash flow of $316.47M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Carl Zeiss Meditec employs approximately 5,784 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
The free float of Carl Zeiss Meditec is 33.87M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$3.12B
EPS (TTM) 
$1.258
Free Float 
33.87M
P/E ratio (TTM) 
28.37
Revenue (TTM) 
$2.52B
EBITDA (TTM) 
$376.86M
Free Cashflow (TTM) 
$316.47M

Pricing

1D span
$35.67$36.99
52W span
$26.27$56.10

Analyst Ratings

The price target is $32.25 and the stock is covered by 17 analysts.

Buy

1

Hold

11

Sell

5

Information

Carl Zeiss Meditec AG engages in the development, manufacture, and marketing of medical devices. It operates through the Ophthalmic Strategic Business Unit (SBU) and Microsurgery business SBU segments. The Ophthalmic SBU segment includes intraocular lenses, surgical visualization solutions, and medical laser and diagnostic systems. The Microsurgery SBU segment offers surgical microscopes and visualization solutions for neuro, ear, nose, and throat surgery, as well as the activities in the field of intraoperative radiotherapy. The company was founded in 2002 and is headquartered in Jena, Germany.

Employees
5,784
Industries
Medical Specialties
Sector
Health Care

Identifier

ISIN
DE0005313704
Primary Ticker
AFX

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation